Skip navigation
Agenda

Action Plan Strategies for Long-Term Success

January 22-23, 2019
  • Alexandria, VA

Agenda

Want more agenda details? Download the brochure.

DAY ONE Tuesday, January 22, 2019

7:30

Conference Registration and Continental Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

Cate Lockhart, PharmD, PhD
Program Director
Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

Navigate Evolving Regulations
to Stramline Pathways

8:45

BIOSIMILAR NEWS SPOTLIGHT Evaluate Current Actions and Breakthrough Guidance Reshaping and Revitalizing the Marketplace

MODERATOR:

Eric R. Sjogren, MS, MBA, RPh
Former Director, Strategic Business Intelligence
Merck

PANELISTS:

Anna Rose Welch
Chief Editor, Biosimilar Development
Life Science Connect

Brian Lehman, MBA, MHA, RPh
Director, Medical Account Management and Strategic Alliances
Sandoz Inc

Alexandra Valenti
Associate
Goodwin Procter LLP

9:30

The Biosimilar Action Plan — Clarify FDA’s Guidance

Speaker TBA

10:15

Networking and Refreshment Break

10:45

Navigate the Patent Thicket — Effect of Extensions on Biosimilars

Alexandra Valenti
Associate
Goodwin Procter LLP

11:30

Crack the Code — Break Down Medicare Part B for Biosimilars

Molly Burich
Director of Public Policy, Biosimilars and Reimbursement
Boehringer Ingelheim

12:15

Networking Luncheon

Educating Stakeholders to Accelerate
Biosimilar Uptake

1:30

MULTI-STAKEHOLDER PANEL Shrink the Knowledge Gap on Biosimilars —
Educate Your Audience to Increase Adoption

MODERATOR:

Anna Rose Welch
Chief Editor, Biosimilar Development
Life Science Connect

PANELISTS:

Laura Wingate
Senior Vice President, Education, Support, Advocacy
Crohns and Colitis Foundation

Jesse Peterson, PharmD, MS, CSP
Clinical Development Manager
Fairview Specialty Pharmacy

Mona Chitre
Vice President, Pharmacy Management and Workplace Wellness
Excellus BlueC BlueShield

2:15

CASE STUDY 3D Thinking — Biosimilars Growth Strategy for Employers

Troy Ross
President and CEO
Mid-America Coalition on Healthcare

3:00

Networking and Refreshment Break

3:30

Human Nature vs. Regulatory Reality in Commercialization

Laura Wingate
Senior Vice President, Education, Support, Advocacy
Crohns and Colitis Foundation

4:15

CASE STUDY Leverage Real-World Evidence in the U.S. Biosimilars Market

Cate Lockhart, PharmD, PhD
Program Director
Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO Wednesday, January 23, 2019

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Cate Lockhart, PharmD, Ph.D
Program Director
Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

8:45

KEY NOTE ADDRESS Commercial Considerations and Market Access for New Launches – Identifying Best Practices for Market Adoption

Speaker TBA

9:30

PAYER TOWN HALL Tackle Biosimilar Adoption Through the Eyes of a Payer

Speaker TBA

10:15

Networking and Refreshment Break

Accelerate Market Access and
Enhance Commercial Strategy

10:45

The Value of Employers — How Can Employers Support Biosimilar Market Adoption?

CONVERSATION CONTRIBUTORS:

Brian Lehman, MBA, MHA, RPh
Director, Medical Account Management and Strategic Alliances
Sandoz Inc

Lauren Vela
Senior Director, Member Value
Pacific Business Group on Health

Matthew Harman
Director of Pharmacy
Employers Health Coalition, Inc.

11:30

Commercial Considerations for Drug Pricing in the Biosimilars Market

Edric Engert
Managing Director, Abraxeolus Consulting;
Former Senior Vice President, Teva Pharmaceuticals

12:15

Networking Luncheon

1:30

U.S. AND EUROPE HIGHLIGHT Opportunities for the Global Development of Biosimilars by Leveraging a Global Comparator Reference Product

Gillian Woollett
Senior Vice President
Avalere Health

2:15

BIOSIMILAR THINK TANK Tailored Table Talks on Access, Reimbursement and Legal Considerations

FACILITATORS:

Gerard Taglianetti
Director, Contract Strategy U.S. Payer and Channel Access
National Business Group on Health

Cate Lockhart, PharmD, Ph.D
Program Director
Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

3:15

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE Tuesday, January 22, 2019

7:30

Conference Registration and Continental Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

Cate Lockhart, PharmD, PhD
Program Director
Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

Navigate Evolving Regulations
to Stramline Pathways

8:45

BIOSIMILAR NEWS SPOTLIGHT Evaluate Current Actions and Breakthrough Guidance Reshaping and Revitalizing the Marketplace

MODERATOR:

Eric R. Sjogren, MS, MBA, RPh
Former Director, Strategic Business Intelligence
Merck

PANELISTS:

Anna Rose Welch
Chief Editor, Biosimilar Development
Life Science Connect

Brian Lehman, MBA, MHA, RPh
Director, Medical Account Management and Strategic Alliances
Sandoz Inc

Alexandra Valenti
Associate
Goodwin Procter LLP

9:30

The Biosimilar Action Plan — Clarify FDA’s Guidance

Speaker TBA

10:15

Networking and Refreshment Break

10:45

Navigate the Patent Thicket — Effect of Extensions on Biosimilars

Alexandra Valenti
Associate
Goodwin Procter LLP

11:30

Crack the Code — Break Down Medicare Part B for Biosimilars

Molly Burich
Director of Public Policy, Biosimilars and Reimbursement
Boehringer Ingelheim

12:15

Networking Luncheon

Educating Stakeholders to Accelerate
Biosimilar Uptake

1:30

MULTI-STAKEHOLDER PANEL Shrink the Knowledge Gap on Biosimilars —
Educate Your Audience to Increase Adoption

MODERATOR:

Anna Rose Welch
Chief Editor, Biosimilar Development
Life Science Connect

PANELISTS:

Laura Wingate
Senior Vice President, Education, Support, Advocacy
Crohns and Colitis Foundation

Jesse Peterson, PharmD, MS, CSP
Clinical Development Manager
Fairview Specialty Pharmacy

Mona Chitre
Vice President, Pharmacy Management and Workplace Wellness
Excellus BlueC BlueShield

2:15

CASE STUDY 3D Thinking — Biosimilars Growth Strategy for Employers

Troy Ross
President and CEO
Mid-America Coalition on Healthcare

3:00

Networking and Refreshment Break

3:30

Human Nature vs. Regulatory Reality in Commercialization

Laura Wingate
Senior Vice President, Education, Support, Advocacy
Crohns and Colitis Foundation

4:15

CASE STUDY Leverage Real-World Evidence in the U.S. Biosimilars Market

Cate Lockhart, PharmD, PhD
Program Director
Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO Wednesday, January 23, 2019

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Cate Lockhart, PharmD, Ph.D
Program Director
Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

8:45

KEY NOTE ADDRESS Commercial Considerations and Market Access for New Launches – Identifying Best Practices for Market Adoption

Speaker TBA

9:30

PAYER TOWN HALL Tackle Biosimilar Adoption Through the Eyes of a Payer

Speaker TBA

10:15

Networking and Refreshment Break

Accelerate Market Access and
Enhance Commercial Strategy

10:45

The Value of Employers — How Can Employers Support Biosimilar Market Adoption?

CONVERSATION CONTRIBUTORS:

Brian Lehman, MBA, MHA, RPh
Director, Medical Account Management and Strategic Alliances
Sandoz Inc

Lauren Vela
Senior Director, Member Value
Pacific Business Group on Health

Matthew Harman
Director of Pharmacy
Employers Health Coalition, Inc.

11:30

Commercial Considerations for Drug Pricing in the Biosimilars Market

Edric Engert
Managing Director, Abraxeolus Consulting;
Former Senior Vice President, Teva Pharmaceuticals

12:15

Networking Luncheon

1:30

U.S. AND EUROPE HIGHLIGHT Opportunities for the Global Development of Biosimilars by Leveraging a Global Comparator Reference Product

Gillian Woollett
Senior Vice President
Avalere Health

2:15

BIOSIMILAR THINK TANK Tailored Table Talks on Access, Reimbursement and Legal Considerations

FACILITATORS:

Gerard Taglianetti
Director, Contract Strategy U.S. Payer and Channel Access
National Business Group on Health

Cate Lockhart, PharmD, Ph.D
Program Director
Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

3:15

Close of Conference